ReviewBritish journal of clinical pharmacology2018
Drug promotion practices: A review.
Review in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pharmaceutical policies: effects of policies regulating drug marketing.The Cochrane database of systematic reviews · 2023Pooled it
- The influence of the pharmaceutical industry and the pharmacy sector on Aboriginal and Torres Strait Islander health: a yarning study.Health promotion international · 2026Article
- Pediatricians Facing Industry-Sponsored Pressures: Key Ethical Considerations.Indian pediatrics · 2026Review
- Laser Prophylaxis for Dry Age-Related Macular Degeneration: Current Evidence.Journal of clinical medicine · 2025Review
- Ask a Doctor a Question: A Clinician's Message to the Industry.Medicina (Kaunas, Lithuania) · 2025Article
- Surveillance of drug prescribing: why outliers miss their targets - a qualitative study.BMC health services research · 2025Article
- Assessing the effects of online educational intervention on pharmaceutical promotions: a pre-post study among medical and pharmacy students in Pakistan.Frontiers in pharmacology · 2025Article
- Stakeholder analysis of banning unhealthy product advertisement in Iran.BMC health services research · 2024Article
- Evaluation of Drug and Herbal Medicinal Promotions on Social Media During the COVID-19 Pandemic in Relation to World Health Organization Ethical Criteria and South African Health Products Regulatory Authority Guidelines in South Africa: Cross-Sectional Content Analysis.Online journal of public health informatics · 2024Article
- Redefining the Role of Medical Affairs Professionals as Innovators and Leaders in Industry-Led Medical Education.Pharmaceutical medicine · 2024Article
- Pharmaceutical Drug Promotion and Rational Drug Use: Assessment of Healthcare Workers Perspective.Integrated pharmacy research & practice · 2024Article
- The Evolving Landscape of Pharmaceutical Regulation: Striking a Balance between Innovation and Safety.Current drug discovery technologies · 2024Article
- Journey from an Enabler to a Strategic Leader: Integration of the Medical Affairs Function in ESG Initiatives and Values.Pharmaceutical medicine · 2023Article
- Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.Neurology · 2023Review
- Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance.Globalization and health · 2023Article
- Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.Frontiers in pharmacology · 2022Article
- Evaluation of Medication Package Inserts in Ethiopia.Journal of environmental and public health · 2022Article
- Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis.Exploratory research in clinical and social pharmacy · 2021Article
- Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.International urogynecology journal · 2021Article
- Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.International journal of molecular sciences · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the years, the pharmaceutical industry has been at the forefront of research and innovation in drug discovery and development. The process of drug discovery extending from preclinical studies to multicentric clinical trials and postmarketing phase is a costly affair running into billions of dollars. On the flip side, not all investigational molecules clear the trial phases and get approved, which puts pressure on the manufacturers to maximize the profit from approved drugs. It is in this key area that the practice of drug promotion plays its role. The World Health Organization defines drug promotion as "all informational and persuasive activities by manufacturers and distributors, the effect of which is to influence the prescription, supply, purchase or use of medicinal drugs". With its humble intent of creating awareness among healthcare professionals and updating their knowledge on recent advances in treatment options, drug promotion has been an important tool, but gradually it has evolved to embrace aggressive marketing strategies and sometimes unethical business and scientific practices where the need for profit-making eclipses commitment to patient care and scientific exploration. In this review, we discuss the evolution of drug promotion practices, the various types, its merits and demerits, the influence of drug promotion on physician prescribing behaviour, the role of regulatory bodies, unethical promotional practices and finally summarize with future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.